Skip to main content

The Globe and Mail

Quest Diagnostics Inc (DGX-N) Quote

Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 96.26
Day High 97.24
Open:96.77
Price movement based on the high, low and last over the given period.
Previous Close
Volume
Average Volume
Price/Earnings (TTM)
Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share ttm
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings ttm
Annual Dividend & Yield
Ex-Div Date
Forward P/E
Price/Book
Most Recent Split

Financials

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system
PR Newswire - Mon Dec 11, 10:32AM CST
PR Newswire - CMTX
Mon Dec 11, 10:32AM CST
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced its support for a lawsuit filed by the American Clinical Laboratory Association (ACLA) charging that the Centers for Medicare & Medicaid Services (CMS) failed to follow a congressional directive to implement a market-based laboratory payment system. Quest is a member of ACLA.
Quest Diagnostics Completes Acquisition of Cleveland HeartLab and Formalizes R&D Collaboration with Cleveland Clinic
PR Newswire - Fri Dec 1, 12:00PM CST
PR Newswire - CMTX
Fri Dec 1, 12:00PM CST
Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of Cleveland HeartLab. Quest will establish a national center of excellence focused on heart disease diagnostics within Cleveland HeartLab's existing 25,000 square-foot clinical laboratory facility in Cleveland.
Quest Diagnostics Declares Quarterly Cash Dividend
PR Newswire - Wed Nov 29, 5:45AM CST
PR Newswire - CMTX
Wed Nov 29, 5:45AM CST
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on January 24, 2018 to shareholders of record of Quest Diagnostics common stock on January 9, 2018.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 90.31 +7.52% increase
on 11/20/17
Period Open:92.05
Price movement based on the high, low and last over the given period.
102.62 -5.38% decrease
on 12/04/17
+5.05 (+5.49%) increase
since 11/10/17
3-Month 90.10 +7.77% increase
on 10/19/17
Period Open:108.23
Price movement based on the high, low and last over the given period.
108.63 -10.61% decrease
on 09/12/17
-11.13 (-10.28%) decrease
since 09/11/17
52-Week 90.10 +7.77% increase
on 10/19/17
Period Open:91.14
Price movement based on the high, low and last over the given period.
112.96 -14.04% decrease
on 07/03/17
+5.96 (+6.54%) increase
since 12/09/16

All market data is provided by Barchart Solutions (will open in new tab). Copyright © 2017.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement